Research has determined that SIRT1 expression and activity are down in patients with chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease, which are associated with the long-term activation of ER stress and the NF-kB signaling pathway (Zhang et al., 2009). Here, NFKB1 is linked to inflammatory bowel disease.